| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AC and Weekly Paclitaxel Improve Outcomes in TNBC
|
Parry, Nicola
|
|
2014
|
|
56 |
p. 7-8
|
artikel
|
| 2 |
American Association for Cancer Research, San Antonio Breast Cancer Symposium 2014: Advisors’ Introduction
|
Tolaney, Sara
|
|
2014
|
|
56 |
p. ii-ii
|
artikel
|
| 3 |
Current Perspectives on HER2-Positive BC
|
Parry, Nicola
|
|
2014
|
|
56 |
p. 17-18
|
artikel
|
| 4 |
Current Perspectives on Neoadjuvant Treatment of ER-Positive BC
|
Parry, Nicola
|
|
2014
|
|
56 |
p. 19-20
|
artikel
|
| 5 |
Evidence-Based AET in Women Before and After Menopause
|
Mosley, Mary
|
|
2014
|
|
56 |
p. 13-14
|
artikel
|
| 6 |
Harnessing Genomics and Molecular Profiling in ER-Positive BC for New Therapies
|
Mosley, Mary
|
|
2014
|
|
56 |
p. 4-5
|
artikel
|
| 7 |
Heterogeneity, Genome Complexity of TNBC Complicate Therapy
|
Kuznar, Wayne
|
|
2014
|
|
56 |
p. 23-24
|
artikel
|
| 8 |
Highlights and Future Directions in AI Clinical Research
|
Cunningham, Muriel
|
|
2014
|
|
56 |
p. 16-16
|
artikel
|
| 9 |
ICE: No Advantage to Adding Capecitabine to Ibandronate in High-Risk Early BC
|
Lederman, Lynne
|
|
2014
|
|
56 |
p. 9-9
|
artikel
|
| 10 |
Identification of Drivers of Metastasis in BC
|
Lederman, Lynne
|
|
2014
|
|
56 |
p. 14-15
|
artikel
|
| 11 |
Most Genes Associated With Increased Risk of BC Remain Poorly Characterized
|
Lederman, Lynne
|
|
2014
|
|
56 |
p. 28-29
|
artikel
|
| 12 |
New Biology Identified by PGx Is Foundation for New Strategies in BC
|
Mosley, Mary
|
|
2014
|
|
56 |
p. 2-3
|
artikel
|
| 13 |
No Survival Benefit When Adding Everolimus to Trastuzumab and Paclitaxel in Advanced HER2-Positive BC
|
Parry, Nicola
|
|
2014
|
|
56 |
p. 11-12
|
artikel
|
| 14 |
Overcoming Tumor Diversity and Adaptability Key to Effective Therapies in BC
|
Cunningham, Muriel
|
|
2014
|
|
56 |
p. 15-16
|
artikel
|
| 15 |
Partial and Whole Breast Radiation Have Similar Outcomes in Early BC
|
Cunningham, Muriel
|
|
2014
|
|
56 |
p. 10-10
|
artikel
|
| 16 |
Radiation Benefits Many but Not Necessarily All Patients With BC
|
Lederman, Lynne
|
|
2014
|
|
56 |
p. 21-22
|
artikel
|
| 17 |
Reasons for Rise in CPM Explored
|
Kuznar, Wayne
|
|
2014
|
|
56 |
p. 25-27
|
artikel
|
| 18 |
Results From the EPO-ANE-3010 Study Consistent With US Black Box Labeling
|
Cunningham, Muriel
|
|
2014
|
|
56 |
p. 12-12
|
artikel
|
| 19 |
TNT Results: Carboplatin Improves Patient Outcomes in Advanced BRCA1/2-Mutated BC
|
Parry, Nicola
|
|
2014
|
|
56 |
p. 6-7
|
artikel
|
| 20 |
TP53 Mutations Are Associated With Increased Pathologic Complete Response in HER2-Positive BC
|
Lederman, Lynne
|
|
2014
|
|
56 |
p. 8-9
|
artikel
|
| 21 |
Update on Epigenetic Agents in the Treatment of BC
|
Cunningham, Muriel
|
|
2014
|
|
56 |
p. 30-31
|
artikel
|
Tijdschrift beschrijving